6.7100
29-11月-24 13:30:00
15 分の遅延
株式
+0.1700
+2.60%
本日の幅
6.5000 - 6.7500
ISIN
N/A
ソース
NYSE
Annovis Bio Announces Issuance of U.S. Patent Covering the Use of Lead Drug Candidate, Buntanetap, for Prevention or Treatment of Disease States Due to Metal Dis-Homeostasis in Healthy or Sick Humans
27 4 2023 07:00:00 提供 Nasdaq GlobeNewswire
Annovis Bio, Inc. to present at the Q1 Virtual Investor Summit
11 3 2021 07:05:00 提供 Nasdaq GlobeNewswire
Annovis Bio to Present at the BIO CEO & Investor Digital Conference
16 2 2021 06:45:00 提供 Nasdaq GlobeNewswire